NCT06750536 - Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

Extracorporeal Membrane Oxygenation ComplicationNeonatal Aspiration PneumoniaAcute Respiratory FailureAcute Lung Injury

Interventions

DEVICE

MiniLung petite kit combined with the Xenios console

Veno-venous (VV) and veno-arterial (VA) Extracorporeal Membrane Oxygenation (ECMO) treatment will be performed using the MiniLung petite kit combined with the Xenios console according to their intended use and local standards/requirements.

Trial Locations (2)

53127

Universitätsklinkum Bonn, Bonn

68167

Universitätsklinikum Mannheim, Mannheim